Supplemental Annuity Collective Trust of NJ reduced its holdings in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 56.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,000 shares of the company’s stock after selling 9,000 shares during the period. Supplemental Annuity Collective Trust of NJ’s holdings in Express Scripts were worth $665,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of ESRX. Landaas & Co. WI ADV bought a new position in shares of Express Scripts in the second quarter worth approximately $102,000. Kaizen Advisory LLC grew its holdings in shares of Express Scripts by 147.6% in the second quarter. Kaizen Advisory LLC now owns 1,342 shares of the company’s stock worth $104,000 after purchasing an additional 800 shares during the last quarter. Adviser Investments LLC grew its holdings in shares of Express Scripts by 321.9% in the second quarter. Adviser Investments LLC now owns 1,481 shares of the company’s stock worth $114,000 after purchasing an additional 1,130 shares during the last quarter. Sun Life Financial INC grew its holdings in shares of Express Scripts by 758.8% in the second quarter. Sun Life Financial INC now owns 1,520 shares of the company’s stock worth $117,000 after purchasing an additional 1,343 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. grew its holdings in shares of Express Scripts by 3,048.1% in the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,637 shares of the company’s stock worth $126,000 after purchasing an additional 1,585 shares during the last quarter. Institutional investors and hedge funds own 84.73% of the company’s stock.

In related news, insider Christine Houston sold 12,898 shares of the firm’s stock in a transaction on Friday, August 10th. The stock was sold at an average price of $85.00, for a total value of $1,096,330.00. Following the completion of the sale, the insider now owns 110,908 shares of the company’s stock, valued at $9,427,180. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.79% of the company’s stock.

Several brokerages have recently issued reports on ESRX. BidaskClub upgraded shares of Express Scripts from a “buy” rating to a “strong-buy” rating in a report on Friday. Zacks Investment Research cut shares of Express Scripts from a “hold” rating to a “sell” rating in a report on Monday, July 23rd. William Blair upgraded shares of Express Scripts from a “market perform” rating to an “outperform” rating in a report on Wednesday, August 1st. Robert W. Baird cut shares of Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 target price on the stock. in a report on Friday, July 20th. Finally, Royal Bank of Canada raised their target price on shares of Express Scripts to $94.00 and gave the stock an “outperform” rating in a report on Monday, August 27th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Express Scripts presently has an average rating of “Hold” and an average price target of $86.36.

Shares of ESRX stock opened at $93.52 on Tuesday. Express Scripts Holding Co has a 52 week low of $55.80 and a 52 week high of $97.22. The firm has a market capitalization of $53.41 billion, a P/E ratio of 13.17, a price-to-earnings-growth ratio of 1.20 and a beta of 1.01. The company has a quick ratio of 0.59, a current ratio of 0.71 and a debt-to-equity ratio of 0.69.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings results on Wednesday, August 1st. The company reported $2.22 EPS for the quarter, topping analysts’ consensus estimates of $2.20 by $0.02. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The company had revenue of $25.64 billion during the quarter, compared to analyst estimates of $25.43 billion. During the same quarter last year, the firm posted $1.73 earnings per share. The firm’s revenue was up 1.2% on a year-over-year basis. Sell-side analysts anticipate that Express Scripts Holding Co will post 9.07 EPS for the current fiscal year.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

See Also: How to Invest in the Dividend Aristocrat Index

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.